Exploring the modulation of MLH1 and MSH2 gene expression in hesperetin-treated breast cancer cells (BT-474)
- PMID: 38389973
- PMCID: PMC10880915
- DOI: 10.4103/japtr.japtr_279_23
Exploring the modulation of MLH1 and MSH2 gene expression in hesperetin-treated breast cancer cells (BT-474)
Abstract
The major mortality factor for women globally is breast cancer, and current treatments have several adverse effects. Hesperetin (HSP) is a flavone that occurs naturally with anti-tumor capabilities and has been investigated as a potential treatment for cancer. This study aimed to investigate the cytotoxic and anti-malignant potential of HSP on breast cancer cells (BT-474) and normal cells (MCF-10a). The results indicated that HSP has dose-dependent cytotoxicity in BT-474 and MCF-10a cells. The elevated concentration of HSP lowered cell viability and proliferation. The half-maximal inhibitory concentration (IC50) of HSP in BT-474 cancer cells after a 48-h exposure was 279.2 μM/ml, while the IC50 in normal cells was 855.4 μM/ml. The cytotoxicity of HSP was more significant in cancer cell lines than in normal cell lines and this aspect presents a favorable factor in utilizing the drug for the treatment of breast cancer. The apoptotic effect of HSP in BT-474 cells was investigated, and it was found that the higher the concentration of HSP more the cells underwent apoptosis. Furthermore, the highest concentration of HSP led to overexpression of the MLH1 and MSH2 genes in both breast cancer and normal cell lines. Overall, our study suggests that HSP has an anticancer effect on breast cancer cell lines, and the effect is concentration dependent.
Keywords: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay; Apoptosis; MLH1 gene expression; MSH2 gene expression; breast cancer; cytotoxicity; flow cytometry; half-maximal inhibitory concentration; hesperetin; malignancy; real-time polymerase chain reaction.
Copyright: © 2024 Journal of Advanced Pharmaceutical Technology & Research.
Conflict of interest statement
There are no conflicts of interest.
Figures




Similar articles
-
Hesperetin effect on MLH1 and MSH2 expression on breast cancer cells BT-549.J Adv Pharm Technol Res. 2023 Jul-Sep;14(3):241-247. doi: 10.4103/japtr.japtr_277_23. Epub 2023 Jul 28. J Adv Pharm Technol Res. 2023. PMID: 37692022 Free PMC article.
-
Study of hesperetin effect on modulating transcription levels of MLH1 and MSH2 genes in SKBR3 breast cancer cell line.J Adv Pharm Technol Res. 2023 Oct-Dec;14(4):338-344. doi: 10.4103/JAPTR.JAPTR_278_23. Epub 2023 Oct 30. J Adv Pharm Technol Res. 2023. PMID: 38107455 Free PMC article.
-
Modulation of expression of heat shock proteins and apoptosis by Flueggea leucopyrus (Willd) decoction in three breast cancer phenotypes.BMC Complement Altern Med. 2015 Nov 9;15:404. doi: 10.1186/s12906-015-0927-6. BMC Complement Altern Med. 2015. PMID: 26553005 Free PMC article.
-
The apoptotic effect of hesperetin on human cervical cancer cells is mediated through cell cycle arrest, death receptor, and mitochondrial pathways.Fundam Clin Pharmacol. 2013 Dec;27(6):581-92. doi: 10.1111/j.1472-8206.2012.01061.x. Epub 2012 Aug 23. Fundam Clin Pharmacol. 2013. PMID: 22913657
-
Chemotherapeutic potential of hesperetin for cancer treatment, with mechanistic insights: A comprehensive review.Heliyon. 2022 Jan 23;8(1):e08815. doi: 10.1016/j.heliyon.2022.e08815. eCollection 2022 Jan. Heliyon. 2022. PMID: 35128104 Free PMC article. Review.
Cited by
-
The Effect of NF-κB Deactivation on Cancer Cell Response to ALA Mediated Photodynamic Therapy.Asian Pac J Cancer Prev. 2024 Jun 1;25(6):2051-2058. doi: 10.31557/APJCP.2024.25.6.2051. Asian Pac J Cancer Prev. 2024. PMID: 38918667 Free PMC article.
References
-
- DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA Cancer J Clin. 2016;66:31–42. - PubMed
-
- Maffini MV, Soto AM, Calabro JM, Ucci AA, Sonnenschein C. The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci. 2004;117:1495–502. - PubMed
LinkOut - more resources
Full Text Sources